- TRADE NAME: Requip (GSK)
- INDICATIONS: Parkinsonism
- CLASS: Dopamine receptor agonist
- HALF-LIFE: ~6 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Ciprofloxacin, Estradiol, Levomepromazine, Norfloxacin, Risperidone, Warfarin, Zuclopenthixol
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of ropinirole prolonged release formulation in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 03/09/2024
